Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Junya Miyamoto"'
Autor:
Ai Haraguchi, Riyoko Shigeno, Ichiro Horie, Shimpei Morimoto, Ayako Ito, Ko Chiba, Yurika Kawazoe, Shigeki Tashiro, Junya Miyamoto, Shuntaro Sato, Hiroshi Yamamoto, Makoto Osaki, Atsushi Kawakami, Norio Abiru
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-9 (2020)
Abstract Background Older patients with type 2 diabetes mellitus (T2DM) have an increased risk of bone fracture independent of their bone mineral density (BMD), which is explained mainly by the deteriorated bone quality in T2DM compared to that in no
Externí odkaz:
https://doaj.org/article/fdf9629034cc4ffe9adb2483660b1086
Autor:
Tomohiro Koga, Shuntaro Sato, Junya Miyamoto, Naoko Hagimori, Yurika Kawazoe, Kumiko Arinaga, Chizu Fukushima, Hiroshi Yamamoto, Atsushi Kawakami
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-9 (2018)
Abstract Background Familial Mediterranean fever (FMF) is an inherited disorder caused by a number of mutations of the Mediterranean fever (MEFV) gene, coding a protein named pyrin that acts as a major regulatory component of the inflammasome. The fi
Externí odkaz:
https://doaj.org/article/38864476973240ef8dc9ce3cde7be6e0
Autor:
Sayaka Kuba, Hiroki Moriuchi, Kosho Yamanouchi, Kenichiro Shibata, Hiroshi Yano, Masahiro Oikawa, Shigeto Maeda, Xiangyue Meng, Michi Morita, Toshiko Hatachi, Ryota Otsubo, Megumi Matsumoto, Junya Miyamoto, Kengo Kanetaka, Hideki Taniguchi, Takeshi Nagayasu, Susumu Eguchi
Publikováno v:
Contemporary Clinical Trials Communications, Vol 21, Iss , Pp 100739- (2021)
Survival of patients with breast cancer can be prolonged by treatment with drugs, particularly new molecular-targeted drugs. However, these agents can be expensive and such treatments can be “an economic burden.” In this ongoing trial, we aim to
Externí odkaz:
https://doaj.org/article/667f7321768f4774a078d339ad4b14ca
Autor:
Shuntaro Sato, Hiroshi Yano, Sayaka Kuba, Kosho Yamanouchi, Megumi Matsumoto, Shigeto Maeda, Toshiko Hatachi, Soutome Sakiko, Yumiko Kawashita, Michi Morita, Chika Sakimura, Eiko Inamasu, Kenichiro Shibata, Ryota Otsubo, Seiichi Nose, Junya Miyamoto, Kengo Kanetaka, Hideki Taniguchi, Masahiro Umeda, Takeshi Nagayasu, Susumu Eguchi
Publikováno v:
BMJ Open, Vol 10, Iss 2 (2020)
IntroductionStomatitis is a frequent adverse event in patients undergoing chemotherapy for breast cancer. Stomatitis can hamper oral nutrition resulting in malnutrition, reduce quality of life and introduce the need for dose reductions and interrupti
Externí odkaz:
https://doaj.org/article/5e72b3b7fd8e4255828ba1783f248181
Autor:
Kiyoyuki Eishi, Takashi Miura, Shogo Yokose, Tsuneo Ariyoshi, Junya Miyamoto, Ichiro Matsumaru, Kikuko Obase, Takashi Shimada, Yuichi Tasaki, Shun Nakaji
Publikováno v:
The Annals of Thoracic Surgery. 109:1335-1342
Mitral valve (MV) repair for infective endocarditis (IE) is sometimes challenging. We investigated the durability of repair associated with the location of the infected lesion.The study comprised 83 patients (55 ± 18 years; active, 66; healed, 17) w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e8811478bb3db690cfba79021778504
https://doi.org/10.1016/j.athoracsur.2019.10.010
https://doi.org/10.1016/j.athoracsur.2019.10.010
Autor:
Satoshi Miuma, Kazuhiko Nakao, Ryu Sasaki, Junya Miyamoto, Hidetaka Shibata, Shuntaro Sato, Hisamitsu Miyaaki, Masafumi Haraguchi, Naota Taura, Masanori Fukushima
Publikováno v:
Internal Medicine
Objective The influence of interferon (IFN)-free direct-acting antiviral (DAA) on hepatocellular carcinoma (HCC) recurrence remains unclear. Previous retrospective analyses revealed that the time interval between HCC curative treatment and IFN-free D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3af5b51432a19fae2dc846abc0cd399a
https://nagasaki-u.repo.nii.ac.jp/records/710
https://nagasaki-u.repo.nii.ac.jp/records/710
Autor:
Ryota Otsubo, Kengo Kanetaka, Junya Miyamoto, Toshiko Hatachi, Kosho Yamanouchi, Hiroshi Yano, Masahiro Oikawa, Megumi Matsumoto, Hiroki Moriuchi, Ken-ichiro Shibata, Michi Morita, Takeshi Nagayasu, Sayaka Kuba, Xiangyue Meng, Hideki Taniguchi, Shigeto Maeda, Susumu Eguchi
Publikováno v:
Contemporary Clinical Trials Communications, Vol 21, Iss, Pp 100739-(2021)
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications
Survival of patients with breast cancer can be prolonged by treatment with drugs, particularly new molecular-targeted drugs. However, these agents can be expensive and such treatments can be “an economic burden.” In this ongoing trial, we aim to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05b32ca0d16855578be146998cadc816
http://www.sciencedirect.com/science/article/pii/S2451865421000417
http://www.sciencedirect.com/science/article/pii/S2451865421000417
Autor:
Hiroaki Dobashi, Tatsuya Atsumi, Yoshinari Takasaki, Atsushi Kawakami, Kunihiro Ichinose, Hitoshi Hasegawa, K. E. Sada, Yoshihiro Arimura, S. Fukui, Naotake Tsuboi, Yukio Yuzawa, Kunihiro Yamagata, Takahiro Maeda, Hirofumi Makino, Seiichi Matsuo, Masayoshi Harigai, Koichi Amano, Junya Miyamoto, Shoichi Maruyama
Publikováno v:
Scandinavian journal of rheumatology. 49(4)
The complement cascade, especially the alternative pathway of complement, has been shown in basic research to be associated with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV). We aimed to elucidate relationships between
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63366b7f8bd5052b0b17f9a5aa68f20a
https://pubmed.ncbi.nlm.nih.gov/32286129
https://pubmed.ncbi.nlm.nih.gov/32286129
Autor:
Ai Haraguchi, Riyoko Shigeno, Ichiro Horie, Shimpei Morimoto, Ayako Ito, Ko Chiba, Yurika Kawazoe, Shigeki Tashiro, Junya Miyamoto, Shuntaro Sato, Hiroshi Yamamoto, Makoto Osaki, Atsushi Kawakami, Norio Abiru
Background Elderly patients with type 2 diabetes mellitus (T2DM) have an increased risk of bone fracture independent of their bone mineral density (BMD), which is explained mainly by the deteriorated bone quality in T2DM compared to non-diabetic adul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::033dd6f7540cc27c486f42d70ab89f82
https://doi.org/10.21203/rs.2.14017/v2
https://doi.org/10.21203/rs.2.14017/v2
Autor:
Toshimasa Shimizu, Naoki Iwamoto, Mami Tamai, Akinari Mizokami, Katsumi Eguchi, Shoichi Fukui, Yumi Kariya, Tomoki Origuchi, Naoki Matsuoka, Yukitaka Ueki, Akihiko Okayama, Junya Miyamoto, Hideki Nakamura, Tomohiro Koga, Keita Fujikawa, Takahisa Suzuki, Toshiyuki Aramaki, Yushiro Endo, Toshihiko Hidaka, Yayoi Hashiba, Kunihiko Umekita, Kunihiro Ichinose, Akitomo Okada, Atsushi Kawakami, Shimpei Morimoto, Shin-ya Kawashiri
Our previous study showed that the effectiveness of tumor necrosis factor (TNF) inhibitors was attenuated in anti-human T-cell leukemia virus type 1 (HTLV-1) antibody-positive patients with rheumatoid arthritis (RA). We aimed to evaluate the effectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d910f36a72fb63d98af012372cdddfd